Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | R3-altibody |
Synonyms | |
Therapy Description |
R3-altibody is a tetravalent bispecific antibody targeting FGFR3, which potentially inhibits Fgfr3 dimerization, downstream signaling, and tumor growth (PMID: 39082679). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
R3-altibody | R3 altibody | FGFR3 Antibody 4 | R3-altibody is a tetravalent bispecific antibody targeting FGFR3, which potentially inhibits Fgfr3 dimerization, downstream signaling, and tumor growth (PMID: 39082679). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FGFR3 S249C FGFR3 V555L | Advanced Solid Tumor | sensitive | R3-altibody | Preclinical - Cell culture | Actionable | In a preclinical study, R3-altibody inhibited Fgfr3 downstream signaling and growth in a cell line expressing FGFR3 S249C and V555L in culture (PMID: 39082679). | 39082679 |
FGFR3 S249C | lung squamous cell carcinoma | sensitive | R3-altibody | Preclinical - Pdx | Actionable | In a preclinical study, R3-altibody inhibited tumor growth in a patient-derived xenograft (PDX) model of lung squamous cell carcinoma harboring FGFR3 S249C (PMID: 39082679). | 39082679 |
FGFR3 S249C | bladder urothelial carcinoma | sensitive | R3-altibody | Preclinical - Cell line xenograft | Actionable | In a preclinical study, R3-altibody inhibited Fgfr3 dimerization and proliferation in a urothelial carcinoma cell line harboring FGFR3 S249C in culture and induced tumor regression in a cell line xenograft model (PMID: 39082679). | 39082679 |
FGFR3 S249C | Advanced Solid Tumor | sensitive | R3-altibody | Preclinical - Cell culture | Actionable | In a preclinical study, R3-altibody inhibited Fgfr3 dimerization and downstream signaling and decreased proliferation in a cell line expressing FGFR3 S249C in culture (PMID: 39082679). | 39082679 |
FGFR3 S249C FGFR3 V555M | Advanced Solid Tumor | sensitive | R3-altibody | Preclinical - Cell culture | Actionable | In a preclinical study, R3-altibody inhibited Fgfr3 downstream signaling and growth in a cell line expressing FGFR3 S249C and V555M in culture (PMID: 39082679). | 39082679 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|